What’s happened in the first six months of Geneva Network – new studies on IP, health and trade. Find out more Post navigation Previous Article Previous Article How will the TPP impact access to medicines and innovation? Next Article Next Article New study: More medicines have their price raised by import duties You may also like Una mala propuesta se gesta en la OMC News Advancing a quality pharmaceutical industry by lowering trade barriers News
What’s happened in the first six months of Geneva Network – new studies on IP, health and trade.
What’s happened in the first six months of Geneva Network – new studies on IP, health and trade.
